1.New Conceptions of Medical Care Model and Clinical Practice
Chinese Medical Ethics 1994;0(05):-
With the development of mdical science and technology, Medical care model has been changed.It can be realized from clinical neurology practice that the changing is necessary and the changing is important for the correct diagnosis and good medical care.
2.Development and use of quality indicators for clinical laboratories
Chinese Journal of Hospital Administration 2011;27(3):211-214
To provide an effective approach to select, develop, interpret and apply well-designed quality indicators. Then to promote the continual improvement of laboratory quality and to assure patient safety. We focused on the quality cycle of selecting, development, implementation and processing for quality indicators. And some examples for essential activities in the development and use of quality indicators were shown. Through the presentation of process and examples, we put forward an organized approach that provides the laboratory with a plan to structure its development of quality indicators to gather useful information. Quality indicators are important. However, they should be integrated with internal review plan, External Quality Assessment (EQA) and the process of activities in plan. Only then can we really promote the continual improvement of quality.
3.Status about cognition of NICU nurses to premature infant family requirement for health education and influencing factors
Chinese Journal of Practical Nursing 2013;29(36):36-38
Objective To investigate the status and influencing factors of nurses' cognition to premature parents' health education demands,so as to provide reference for nursing leaders to take intervention.Methods 59 NICU nurses from two hospitals in Guangzhou and Shenzhen were chosen by convenience sampling.A self-designed questionnaire was used to investigate.Results A total of 56 questionnaires was recovered,with a rate of 94.92%.NICU nurses perceived the degree of parents total education demands was (3.20±0.48) points.The demands of knowledge about diseases progress and related diagnosis and nursing were high,reaching (3.33±0.47) points.Breast feeding got the highest score,(3.53±0.69)points.Ed-ucation,professional ranks,post of nurses had no correlation with total score,but ages and length of service were negatively correlated with general demand,mental nursing and social support.Conclusions NICU nurses value premature parents' health education,and nursing leaders should take interventions to prevent occurrence of job burnout.
5.Research Progress of Streptomyces Cytochrome P450
Mei LI ; Fan-Rong ZENG ;
Microbiology 2008;0(07):-
Cytochrome P450 are abundant in Streptomyces which play an important role in the biosynthesis of secondary products and metabolism of exotic chemicals of Streptomyces. Recent progress and function of cytochrome P450 in Streptomyces were reviewed in this paper. The problems in study of Streptomyces Cytochrome P450, and the prospects for future study of cytochrome P450 and its application were also discussed.
6.Experimental research on antagonistic effect of heme oxygenase-1 on acute mercury chloride induced renal impairment.
Ying ZHANG ; Wei-cheng ZENG ; Rong CHEN ; Shun-rong WANG
Chinese Journal of Industrial Hygiene and Occupational Diseases 2006;24(5):289-290
Animals
;
Heme Oxygenase-1
;
biosynthesis
;
Kidney
;
drug effects
;
metabolism
;
Male
;
Mercuric Chloride
;
toxicity
;
Oxidative Stress
;
drug effects
;
Random Allocation
;
Rats
;
Rats, Wistar
7.Clinical Efficacy of Tegafur Gimeracil Oteracil Potassium Capsule Plus Paclitaxel in Treatment of Advanced Gastric Cancer
Min JIANG ; Yuecan ZENG ; Rong WU
Journal of Medical Research 2015;44(5):52-56
Objective To assess and analyze the efficacy and safety of Tegafur Gimeracil Oteracil Potassium capsule plus paclitaxel against advanced gastric cancer. Methods Totally 61 patients with advanced gastric cancer were randomly divided into two groups: the treatment group(32 cases) and the control group(29 cases). Patients in the treatment group were treated with Tegafur Gimeracil Oteracil Potassium capsule (80mg /m2 ) orally, for 14 days continuously, and paclitaxel (175mg/m2 ) on the first day. Patients in the control group were applied with oxaliplatin (130mg/m2 ) on the first day, and the same dose of Tegafur Gimeracil Oteracil Potassium capsule. The two groups both used three weeks as a cycle. Results All 61 patients were included for analysis. No complete response was ob-served. The overall disease control rate was 84. 4%, 79. 3%, respectively. The median progression free survival time was respectively 5. 6 months and 4. 9 months. The median survival time was respectively 13. 1 months and 13. 6 months. There's no significant difference between the two groups. The adverse effects were mostly tolerable, big part of which grade 1/2, mainly included hematological adverse effects, digestive system adverse effect, fatigue and so on. The incidence of neurotoxic effect of control group was higher than treatment group. Conclusion Tri-weekly paclitaxel combined Tegafur Gimeracil Oteracil Potassium Capsule is safe and effective in patients with advanced gastric cancer, which is worthy further study.
8.Relationship between intracranial hemodynamics and nitric oxide, endothelin and nailfold microcirculation in patients with migraine
Weigong ZHONG ; Juan RONG ; Lin ZENG
Journal of Clinical Neurology 2001;0(05):-
Objective To explore the relationship between intercranial hemodynamics and nitric oxide(NO),endothelin(ET),nailfold microcirculation in patients with migraine.Methods 50 patients with migraine and 40 normal controls underwent the measurement of intracranial hemodynamics,naifold microcirculation and the level of plasma ET,NO.The results of the two groups were compared and analyzed.Results The blood flow velocity of intracranial arteries was significantly higher in the patients than that in the normal controls( P
9.Access and Benefit-sharing Regime and Its Application in the Field of Chinese Medicine
Zhen ZENG ; Feng CHANG ; Rong SHAO
China Pharmacy 2007;0(30):-
OBJECTIVE:To put forward the tentative idea of the application of the access and benefit-sharing regime in the field of Chinese medicine.METHODS:The existing problems of protecting biological diversity in the field of Chinese medicine and what problems the access and benefit-sharing regime could solve were analyzed.RESULTS & CONCLUSION:Our preliminary idea for applying access and benefit-sharing regime in the field of Chinese medicine is to set up a special department for negotiation,identify the rights and subject,construct registration system and informed consent procedure,improve the source disclosure system and add the benefit-sharing regulation.
10.Experimental Study on the Estrogenic Activity of Dibutyl Phthalate
Journal of Environment and Health 1992;0(04):-
Objective To determine the estrogenic activity of dibutyl phthalate DBP. Methods The tested compound was dibutyl phthalate. Human estrogen-dependent MCF-7 breast cancer cells were cultured in RPMI 1640 medium containing 10% fetal bovine serum FBS. Five days before the addition of the tested compounds the cells were rinsed by phosphate balanced solution PBS and the medium was substituted with a phenol red-free RPMI 1640 medium containing 5% dextral charcoal-stripped FBS. The respective tested compound was added in fresh medium and the control cells received only the vehicle ethanol. The proliferation of MCF-7 cells was analyzed by the MTT assay growth curves mitotic index and coloning efficiency. Results Compared with the control the proliferation of tested cells treated with DBP like estradiol was markedly enhanced and the activity of the cell proliferation reached the maximum at 10-5 mol/L DBP. During log phase the mitotic index of the test cells treated with DBP and estradiol was significantly increased. The cell coloning efficiency was enhanced which was treated by 10-5 mol/L DBP only for 48 hours. The results showed the time-dependent and dose-dependent model. Conclusion Dibutyl phthalate may enhance the proliferation of human breast cancer MCF-7 cells in vitro that demonstrates an estrogenic activity of dibutyl phthalate.